Clinical Trial Update: 1H-19F Gastrointestinal MRI in Health and IBS

View source ↗

Summary

A University of Zurich-sponsored trial using 1H-19F gastrointestinal MRI in individuals with Irritable bowel syndrome has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Snippet

Sponsor: University of Zurich | Conditions: Irritable Bowel Syndrome | Status: SUSPENDED